Harpoon Therapeutics, Inc. HARP
Set alert
23.01 0.00 0.00%
At close · Mar 8
22.99 Day range 23.02
52-week range unavailable
- Open
- 23.00
- Prev close
- 23.01
- Mkt cap
- 492.35M
- Vol
- 6.40M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 22.99
- High
- 23.02
- Forward P/E
- -5.09
- Beta
- 2.10
- Short ratio
- 0.37
- Inst. own
- 82.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 25, 2024
- 50-d avg
- 21.62
- 200-d avg
- 11.15
- 1y target
- 24.79
Financial health
Altman Z-Score
0.36 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.4×
FY 2016 5y median -6.2× FY 2022
P/S 0.8×
FY 2016 5y median 23.8× FY 2022
P/B 4.5×
FY 2016 5y median 4.2× FY 2022
P/FCF -0.3×
FY 2016 5y median -11.6× FY 2022
EV/EBITDA 0.2×
FY 2016 5y median -3.1× FY 2022
EV/Sales -0.4×
FY 2016 5y median 23.4× FY 2022
FCF Yield -371.8%
FY 2016 5y median -8.6% FY 2022
Profitability
Gross Margin 90.3%
FY 2016 5y median 100.0% FY 2022
Operating Margin -214.1%
FY 2016 5y median -493.6% FY 2022
Net Margin -210.4%
FY 2016 5y median -576.1% FY 2022
ROE -1243.5%
FY 2016 5y median -86.1% FY 2022
ROIC -285.5%
FY 2016 5y median -38.2% FY 2022
ROA -91.1%
FY 2016 5y median -29.4% FY 2022
Growth (YoY)
Revenue 34.9%
FY 2016 FY 2022
Operating Income 41.5%
FY 2016 FY 2022
EPS (diluted) 60.8%
FY 2016 FY 2022
Free Cash Flow 26.8%
FY 2016 FY 2022
Financial Health
Current Ratio 1.0×
FY 2016 5y median 2.7× FY 2022
Quick Ratio 1.0×
FY 2016 5y median 2.7× FY 2022
Debt / Equity 3.0×
FY 2016 5y median 0.2× FY 2022
Net Debt / EBITDA 0.5×
FY 2016 5y median 0.5× FY 2022
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31